Techno Medica Co (TSE:6678) Piotroski F-Score: 8 (As of Jun. 30, 2026) — 14% Above Median


TSE:6678 Techno Medica Co Ltd TSE:6678
85 GF Score
Price 円1,996.00
GF Value 円2,404.61
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Techno Medica Co Piotroski F-Score?

Techno Medica Co TSE:6678 +0.91% 85 Piotroski F-Score is 8 as of Jun. 30, 2026, which is 14% above its 10-year median of 7.00. GuruFocus rates TSE:6678 with a GF Score™ of 85/100 and a GF Value™ of 円2,404.61 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 806 Medical Devices & Instruments companies, Techno Medica Co ranks better than 98.76% on this metric.

Good Sign:

Piotroski F-Score is 8, indicates a very healthy situation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Techno Medica Co has an F-score of 8. It is a good or high score, which usually indicates a very healthy situation.

The historical rank and industry rank for Techno Medica Co's Piotroski F-Score or its related term are showing as below:

TSE:6678' s Piotroski F-Score Range Over the Past 10 Years
Min: 4   Med: 7   Max: 8
Current: 8

During the past 13 years, the highest Piotroski F-Score of Techno Medica Co was 8. The lowest was 4. And the median was 7.

Techno Medica Co  (TSE:6678) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Techno Medica Co Piotroski F-Score Related Terms


Techno Medica Co Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Techno Medica Co's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Techno Medica Co Piotroski F-Score Chart

Techno Medica Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.00 4.00 7.00 6.00 8.00

Techno Medica Co Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.00 0.00 6.00 0.00 8.00

TSE:6678 vs ABT, SYK, MDT: Piotroski F-Score Comparison

For the Medical Devices subindustry, Techno Medica Co's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Techno Medica Co Piotroski F-Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Techno Medica Co's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Techno Medica Co's Piotroski F-Score falls into.


TSE:6678
85GF Score
Techno Medica Co Ltd TSE:6678
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Net Income was 円1,071 Mil.
Cash Flow from Operations was 円1,100 Mil.
Revenue was 円11,237 Mil.
Gross Profit was 円5,243 Mil.
Average Total Assets from the begining of this year (Mar25)
to the end of this year (Mar26) was (17938.618 + 17966.466) / 2 = 円17952.542 Mil.
Total Assets at the begining of this year (Mar25) was 円17,939 Mil.
Long-Term Debt & Capital Lease Obligation was 円0 Mil.
Total Current Assets was 円15,696 Mil.
Total Current Liabilities was 円3,083 Mil.
Net Income was 円1,005 Mil.

Revenue was 円9,906 Mil.
Gross Profit was 円4,928 Mil.
Average Total Assets from the begining of last year (Mar24)
to the end of last year (Mar25) was (17433.874 + 17938.618) / 2 = 円17686.246 Mil.
Total Assets at the begining of last year (Mar24) was 円17,434 Mil.
Long-Term Debt & Capital Lease Obligation was 円0 Mil.
Total Current Assets was 円15,678 Mil.
Total Current Liabilities was 円3,275 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Techno Medica Co's current Net Income (TTM) was 1,071. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Techno Medica Co's current Cash Flow from Operations (TTM) was 1,100. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar25)
=1070.987/17938.618
=0.05970287

ROA (Last Year)=Net Income/Total Assets (Mar24)
=1004.583/17433.874
=0.05762248

Techno Medica Co's return on assets of this year was 0.05970287. Techno Medica Co's return on assets of last year was 0.05762248. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Techno Medica Co's current Net Income (TTM) was 1,071. Techno Medica Co's current Cash Flow from Operations (TTM) was 1,100. ==> 1,100 > 1,071 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar25 to Mar26
=0/17952.542
=0

Gearing (Last Year: Mar25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar24 to Mar25
=0/17686.246
=0

Techno Medica Co's gearing of this year was 0. Techno Medica Co's gearing of last year was 0. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar26)=Total Current Assets/Total Current Liabilities
=15696.043/3083.152
=5.09090794

Current Ratio (Last Year: Mar25)=Total Current Assets/Total Current Liabilities
=15678.302/3275.163
=4.78702953

Techno Medica Co's current ratio of this year was 5.09090794. Techno Medica Co's current ratio of last year was 4.78702953. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Techno Medica Co's number of shares in issue this year was 6.897. Techno Medica Co's number of shares in issue last year was 6.925. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=5242.729/11236.606
=0.46657585

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=4928.362/9905.864
=0.49751965

Techno Medica Co's gross margin of this year was 0.46657585. Techno Medica Co's gross margin of last year was 0.49751965. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar25)
=11236.606/17938.618
=0.62639196

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar24)
=9905.864/17433.874
=0.56819637

Techno Medica Co's asset turnover of this year was 0.62639196. Techno Medica Co's asset turnover of last year was 0.56819637. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+1+1+1+1+1+0+1
=8

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Techno Medica Co has an F-score of 8. It is a good or high score, which usually indicates a very healthy situation.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 8 mean?
Techno Medica Co (TSE:6678) has a Piotroski F-Score of 8 as of Jun. 30, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Techno Medica Co and its competitors. This is 14% above median its historical median of 7.00. Over the past decade, Techno Medica Co's Piotroski F-Score has ranged from 4.00 to 8.00. According to the industry distribution chart, Techno Medica Co ranks #10 out of 806 companies in the Medical Devices & Instruments industry, placing it in the top 1.2%.
Is Techno Medica Co's Piotroski F-Score too high?
Techno Medica Co's current Piotroski F-Score of 8 is 14% above median its 10-year median of 7.00. Over the past 10 years, this metric has ranged from a low of 4.00 to a high of 8.00. The Medical Devices & Instruments industry median Piotroski F-Score is 5.00. Techno Medica Co's value of 8 is 60% above this industry median. Based on the distribution chart, Techno Medica Co ranks #10 out of 806 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Techno Medica Co has a GF Score™ of 85/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Techno Medica Co's Piotroski F-Score compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Techno Medica Co ranks #10 out of 806 companies for Piotroski F-Score. This places Techno Medica Co in the top 1% of its industry — outperforming the majority of peers. The industry median Piotroski F-Score is 5.00. Techno Medica Co's value of 8 is 60% above this benchmark. Historically, Techno Medica Co's own Piotroski F-Score has ranged from 4.00 to 8.00 over the past decade. While the company's 10-year median is 7.00 vs. the industry median of 5.00, Techno Medica Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Medical Devices & Instruments company?
The median Piotroski F-Score among Medical Devices & Instruments companies is 5.00, based on 806 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Techno Medica Co's current Piotroski F-Score of 8 is 60% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Techno Medica Co and its competitors. For the Medical Devices & Instruments industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Techno Medica Co's current Piotroski F-Score is 8, which is 14% above median its own 10-year median of 7.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Techno Medica Co stock overvalued right now?
Based on GuruFocus' analysis, Techno Medica Co (TSE:6678) is currently considered Modestly Undervalued. The stock's GF Value™ is 円2,404.61, compared to a current price of 円1,996.00 — trading 17% below its estimated fair value. The current Piotroski F-Score is 8, which is 14% above median its 10-year median of 7.00 and 60% above the Medical Devices & Instruments industry median of 5.00. Techno Medica Co's overall GF Score™ is 85/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Techno Medica Co (TSE:6678), the current Piotroski F-Score is 8 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Techno Medica Co (TSE:6678) Overvalued in 2026?

Based on GuruFocus' analysis, Techno Medica Co stock appears to be undervalued. The current stock price of 円1,996.00 is trading 17% below its estimated GF Value™ of 円2,404.61. GuruFocus considers Techno Medica Co to be Modestly Undervalued.

Key valuation signals for TSE:6678:

  • Piotroski F-Score: 8 (14% above median its 10-year median of 7.00)
  • GF Value™: 円2,404.61 vs. price of 円1,996.00 (17% below fair value)
  • GF Score™: 85/100 with 2 warning signs
  • Industry Position: 60% above the Medical Devices & Instruments median (#10 of 806)

No single metric tells the full story. See the TSE:6678 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Techno Medica Co Business Description

Address 5-5-1 Nakamachidai, Tsuzuki-ku, Yokohama, JPN, 224-0041
Techno Medica Co Ltd is engaged in the research, development, manufacturing, and sales of medical and in vitro diagnostic products. The company's products classified under Test Tube preparation systems. Additionally, company also import and export medical equipment and Analytical instrument for clinical examination.
85GF Score

Get the complete analysis for TSE:6678

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,996.00
Price
円2,404.61
GF Value